IndiView Chart of the Week: The Rise and Fall of GLP-1 Stocks
GLP-1 drugs were originally developed for Type 2 diabetes but have gained massive popularity for their effectiveness in treating obesity. Two of the most prominent GLP-1 medications are semaglutide (Novo Nordisk’s Ozempic and Wegovy) and tirzepatide (Eli Lilly’s Mounjaro and Zepbound). These drugs have generated tremendous sales. In 2024 alone,…